Iluzanebart (VGL101), Vigil’s monoclonal antibody program, is not being acquired by Sanofi, and its return to Amgen, the original licensor, and the termination of the exclusive license agreement with ...

Larimar Therapeutics, Inc. (NASDAQ:LRMR) was one of the stocks that was covered in that article. Wall Street analysts believe ...

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

By Nana Yaw Reuben Jr.The Open Forum on Agricultural Biotechnology in Africa a non-governmental organization fostering ...

Regeneron Pharmaceuticals announced Monday it plans to purchase human genetics and biotechnology firm 23andMe from bankruptcy ...

Stellenbosch University (SU) has announced the opening of the LaunchLab CERIBIO, a biotechnology laboratory for biotechnology ...